Pediatrix Medical (MD) Cash from Financing Activities (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash from Financing Activities data on file, last reported at -$27.6 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 357.91% year-over-year to -$27.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$129.1 million (down 33.47% YoY) and the FY2025 annual result came in at -$107.5 million, down 642.11% from the prior year.
• Cash from Financing Activities grew to -$27.6 million in Q1 2026 per MD's latest filing, from -$68.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $108.6 million in Q1 2023 and bottomed at -$256.5 million in Q1 2022.
• The 5-year median for Cash from Financing Activities is -$28.6 million (2025), against an average of -$39.0 million.
• The widest annual swing landed in 2022, when Cash from Financing Activities sank 63000.76%; it then jumped 142.33% in 2023.
• Tracing MD's Cash from Financing Activities over 5 years: stood at -$86.3 million in 2022, then surged by 94.5% to -$4.7 million in 2023, then fell by 4.55% to -$5.0 million in 2024, then tumbled by 1282.99% to -$68.6 million in 2025, then jumped by 59.74% to -$27.6 million in 2026.
• Per Business Quant, the three latest MD Cash from Financing Activities figures stand at -$27.6 million (Q1 2026), -$68.6 million (Q4 2025), and -$28.6 million (Q3 2025).

Peer Comparison